Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 151

Similar articles for PubMed (Select 22027583)

1.

Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool.

Loggi E, Micco L, Ercolani G, Cucchetti A, Bihl FK, Grazi GL, Gitto S, Bontadini A, Bernardi M, Grossi P, Costa AN, Pinna AD, Brander C, Andreone P.

J Hepatol. 2012 Mar;56(3):579-85. doi: 10.1016/j.jhep.2011.09.016. Epub 2011 Oct 23.

PMID:
22027583
2.

High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.

Su WJ, Ho MC, Ni YH, Chen HL, Hu RH, Wu YM, Chang MH, Lee PH.

J Pediatr Gastroenterol Nutr. 2009 Feb;48(2):203-8. doi: 10.1097/MPG.0b013e3181819ad4.

PMID:
19179883
3.

De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation.

Ueda Y, Marusawa H, Egawa H, Okamoto S, Ogura Y, Oike F, Nishijima N, Takada Y, Uemoto S, Chiba T.

Antivir Ther. 2011;16(4):479-87. doi: 10.3851/IMP1771.

PMID:
21685535
4.

Escape hepatitis B virus mutations in recipients of antibody to hepatitis B core antigen-positive liver grafts receiving hepatitis B immunoglobulins.

Roche B, Roque-Afonso AM, Sebagh M, Delvart V, Duclos-Vallee JC, Castaing D, Samuel D.

Liver Transpl. 2010 Jul;16(7):885-94. doi: 10.1002/lt.22084.

6.

Transmission of hepatitis B infection from hepatitis B core antibody--positive liver allografts is prevented by lamivudine therapy.

Yu AS, Vierling JM, Colquhoun SD, Arnaout WS, Chan CK, Khanafshar E, Geller SA, Nichols WS, Fong TL.

Liver Transpl. 2001 Jun;7(6):513-7.

7.

Lamivudine monoprophylaxis for de novo HBV infection in HBsAg-negative recipients with HBcAb-positive liver grafts.

Vizzini G, Gruttadauria S, Volpes R, D'Antoni A, Pietrosi G, Filì D, Petridis I, Pagano D, Tuzzolino F, Santonocito MM, Gridelli B.

Clin Transplant. 2011 Jan-Feb;25(1):E77-81. doi: 10.1111/j.1399-0012.2010.01329.x. Epub 2010 Oct 11.

PMID:
21039887
8.

Use of hepatitis B core antibody-positive donors in orthotopic liver transplantation.

Holt D, Thomas R, Van Thiel D, Brems JJ.

Arch Surg. 2002 May;137(5):572-5; discussion 575-6.

PMID:
11982471
9.

Hepatitis B virus infection in heart transplant recipients in a hepatitis B endemic area.

Ko WJ, Chou NK, Hsu RB, Chen YS, Wang SS, Chu SH, Lai MY.

J Heart Lung Transplant. 2001 Aug;20(8):865-75.

PMID:
11502409
10.

Hepatitis B-positive donors in renal transplantation: increasing the deceased donor pool.

Pilmore HL, Gane EJ.

Transplantation. 2012 Aug 15;94(3):205-10. doi: 10.1097/TP.0b013e31824e3db4.

PMID:
22430067
11.

Liver grafts from anti-hepatitis B core positive donors: a systematic review.

Cholongitas E, Papatheodoridis GV, Burroughs AK.

J Hepatol. 2010 Feb;52(2):272-9. doi: 10.1016/j.jhep.2009.11.009. Epub 2010 Jan 19. Review.

12.
13.

Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.

Giaccone L, Festuccia M, Marengo A, Resta I, Sorasio R, Pittaluga F, Fiore F, Boccadoro M, Rizzetto M, Bruno B, Marzano A.

Biol Blood Marrow Transplant. 2010 Jun;16(6):809-17. doi: 10.1016/j.bbmt.2009.12.533. Epub 2010 Jan 7.

14.

Use of anti-HBc positive allografts in adult liver transplantation: toward a safer way to expand the donor pool.

Donataccio D, Roggen F, De Reyck C, Verbaandert C, Bodeus M, Lerut J.

Transpl Int. 2006 Jan;19(1):38-43.

PMID:
16359375
15.

De novo and apparent de novo hepatitis B virus infection after liver transplantation.

Roche B, Samuel D, Gigou M, Feray C, Virot V, Schmets L, David MF, Arulnaden JL, Bismuth A, Reynes M, Bismuth H.

J Hepatol. 1997 Mar;26(3):517-26.

PMID:
9075658
16.

Safe use of liver grafts from hepatitis B surface antigen positive donors in liver transplantation.

Yu S, Yu J, Zhang W, Cheng L, Ye Y, Geng L, Yu Z, Yan S, Wu L, Wang W, Zheng S.

J Hepatol. 2014 Oct;61(4):809-15. doi: 10.1016/j.jhep.2014.05.003. Epub 2014 May 10.

PMID:
24824283
17.

Twenty-four year single-center experience of hepatitis B virus infection in heart transplantation.

Chen YC, Chuang MK, Chou NK, Chi NH, Wu IH, Chen YS, Yu HY, Huang SC, Wang CH, Tsao CI, Ko WJ, Wang SS.

Transplant Proc. 2012 May;44(4):910-2. doi: 10.1016/j.transproceed.2012.03.040.

PMID:
22564582
18.

Clinical course of de novo hepatitis B infection after pediatric liver transplantation.

Su WJ, Ho MC, Ni YH, Wu JF, Jeng YM, Chen HL, Wu YM, Hu RH, Chang MH, Lee PH.

Liver Transpl. 2010 Feb;16(2):215-21. doi: 10.1002/lt.21980.

19.

Antibodies to hepatitis B surface antigen prevent viral reactivation in recipients of liver grafts from anti-HBC positive donors.

Roque-Afonso AM, Feray C, Samuel D, Simoneau D, Roche B, Emile JF, Gigou M, Shouval D, Dussaix E.

Gut. 2002 Jan;50(1):95-9.

20.

[Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation].

Woo SY, Cho SH, Lee SM, Koh MB, Noh CH, Kim CW, Choi JY, Yang JM, Han JY, Lee YS.

Korean J Hepatol. 2009 Jun;15(2):131-9. doi: 10.3350/kjhep.2009.15.2.131. Korean.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk